Ogawara Kazue, Kuwabara Satoshi, Koga Michiaki, Mori Masahiro, Yuki Nobuhiro, Hattori Takamichi
Department of Neurology, Chiba University School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
J Neurol Sci. 2003 Jun 15;210(1-2):41-5. doi: 10.1016/s0022-510x(03)00013-3.
Anti-GM1 and anti-GM1b antibodies are frequently present in patients with Guillain-Barré syndrome (GBS) and accordingly, the two antibodies often coexist in the same patient. In order to study clinical and laboratory features of anti-GM1b-positive GBS, we analyzed the data of patients with anti-GM1b IgG antibody but no anti-GM1 IgG antibody. Of 86 consecutive patients, 10 had anti-GM1b antibody alone and frequently had acute motor axonal neuropathy (AMAN, 80%) and Campylobacter jejuni infection (60%). Of 10 patients with anti-GM1 antibody alone, four had AMAN, and two had C. jejuni infection. These results showed that GM1b could be a target molecule of autoantibody in the AMAN form of GBS subsequent to C. jejuni infection.
抗GM1和抗GM1b抗体在吉兰-巴雷综合征(GBS)患者中经常出现,因此,这两种抗体常共存于同一患者体内。为了研究抗GM1b阳性GBS的临床和实验室特征,我们分析了抗GM1b IgG抗体阳性但抗GM1 IgG抗体阴性患者的数据。在连续的86例患者中,10例仅具有抗GM1b抗体,且常患有急性运动轴索性神经病(AMAN,80%)和空肠弯曲菌感染(60%)。在仅具有抗GM1抗体的10例患者中,4例患有AMAN,2例有空肠弯曲菌感染。这些结果表明,GM1b可能是空肠弯曲菌感染后GBS的AMAN型自身抗体的靶分子。